CONTACT US

*Category

Required

*Name

Required

*Title

Required

Company

Company Type

*Country/Area

Required

*Tel

Required

*Email

Required

Job Title

*Message

Required

*Verification

Required

AmCad BioMed Corporation

+886-2-2713-6227

marketing@amcadbiomed.com

Fl.5-2, No. 167, Fu Hsing N. RD. Taipei 105, Taiwan

ABOUT US

MILESTONES

Event

R&D

Management

2017

July

--Received CFDA approval for AmCAD-UT Detection

May

--Received U.S. FDA 510(k) clearance for AmCAD-US

April

--Received U.S. FDA 510(k) clearance for AmCAD-UV

2016

December

--Received the 13th National Innovation Award for AmCAD-CA

--Received Drug Research and Development Science and Technology Award for AmCAD-UT® Detection

July

--Received Frost & Sullivan Taiwan Business Best Practice Award

--Received Go-Global Silver Medal Award of Taipei Biotechnology Award

June

--Received TFDA clearance for upgrade version of AmCAD-UT® Detection

May

--Received CE Marking approval for AmCAD-UV

April

--Granted distribution right of China to Huajin Yike Pharmaceutical, based in Zhejiang Province, for AmCAD-UT® Detection with a US$5 million payment obligation

--Received CE Marking approval for AmCAD-US

2015

December

--Received Silver Award of National Biotechnology and Medical Care Quality Award for AmCAD-UT® Detection

March

--Listed on Taiwan’s OTC Stock Market (Code: 4188)

January

--Received TFDA clearance for AmCAD-UT® Detection

2014

April

--Received CE Marking approval for AmCAD-UT Detection 2.0

2013

December

--Listed on Taiwan’s Emerging Stock Market (Code: 4188)

November

--Recommended by Industrial Development Bureau (IDB), MoEA as a qualified technology enterprise for IPO application

October

--Received U.S. FDA 510(k) clearance for AmCAD-UT Detection 2.0

September

--Received Taiwan Healthcare and Agricultural Biotech Industries Innovation and Excellence Award

February

--Started to receive patent approvals for its core technologies in U.S., Singapore, Taiwan, etc

2012

March

--Awarded R&D project Grant, “Development of Calibration Method for Compatibility with Various US Machines”, by Taipei City Government

2011

November

--Received GMP certification for Software Manufacturing

May

--Received the “Certificate of Manufacturer of Medical Devices” after its factory establishment

2010

May

--Received The 7th National Innovation Award

2009

December

--Identified as a company of the emerging medical health care industry in Taiwan by Industrial Development Bureau (IDB)

July

--Awarded Industrial Technology Development Program (TDP) Grant “Computer-assisted thyroid disease ultrasound diagnostic system” by MoEA

June

--Received “Important Emerging Strategic Industry” status approval letter by Industrial Development Bureau(IDB) of Ministry of Economic Affairs(MoEA)

January

--Transferred technology with exclusive authorization from National Taiwan University.

2008

December

--AmCad BioMed Corporation(AmCad) was founded.

Copyright © 2019 AmCad BioMed Corporation. All Rights Reserved. Web Design- rIDEA